CPC A61K 31/426 (2013.01) [A61K 9/0053 (2013.01); A61P 3/10 (2018.01)] | 20 Claims |
1. A method of reducing the incidence of hypoglycemic events in a human subject on insulin therapy, the method comprising administering 400 mg/day to 1200 mg/day of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid or a pharmaceutically acceptable salt thereof to the human subject on insulin therapy, wherein the {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid or a pharmaceutically acceptable salt thereof is orally administered once a day, and wherein the incidence of hypoglycemic events in the human subject is reduced over a period of time relative to baseline.
|